HIV - New Developments
Iván Meléndez-Rivera, MD, FAAFP, AAHIVS

This session will discuss new HIV therapeutics in development within old and new drug classes, which are progressing toward release. The speaker will discuss mechanism of action, side effect profiles from earlier clinical trials and expected placement within the realm of HIV care.
(Handouts)

TB and New Treatment Issues and Diagnostics
Beata Casanas, DO, FACP

This session will present a review of new diagnostic and therapeutic concerns in the treatment of HIV patients infected with TB.
(Handouts)

The Wellness and Health of HIV-infected Women
Carmen D. Zorrilla, MD

In this session special issues related to HIV care and treatment will be covered. The speaker will review the management of women in pre-planning for pregnancy, management during pregnancy, labor, and postpartum. Issues of aging in women will be presented from a preventive health format.
(Handouts)

The Impact of Drug Abuse in HIV Infection in Florida
Allan E. Rodriguez, MD

HIV and its medicines affect the metabolic and endocrine system in a variety of ways. This talk will focus on implications of HIV and antiretroviral therapy on burning metabolic and endocrine issues. Discussion will highlight HIV related insulin resistance, and various aspects of metabolic syndrome. Cardio-vascular diseases and dyslipidemia etiology and management in HIV positive patients will be addressed. The latest clinical studies and their findings on how HIV medicines can increase cardio-vascular events in HIV will be presented.
(Handouts)

HIV and Malignancies
Juan Carlos Ramos, MD

As patients age with HIV, malignancies are experienced within groups of HIV patients. The speaker will review and discuss trends and risk factors for malignancies in the HIV population with information presented from recent conferences. Risk reduction and preventive screening strategies will be reviewed.
(Handouts)

HIV and Coinfections with Hepatitis B and/or C
Dushyantha Jayaweera, MD, FACP

This session will review evaluation for treatment of the coinfected patient, including: when to treat, selection of regimens, management of complications and side effects, as well as monitoring patients who fail treatment. This session will highlight the promise of emerging therapeutics and issues of selection of patients for transplant.
(Handouts pending approval)

Caring for the Aging HIV Population
Luis A. Espinoza, MD, AAHIVS

Information from recent conferences will be reviewed on issues of aging in the HIV-infected population. The speaker will address the importance of patient education to reduce risk factors, as well as recommendations for monitoring and screening and treatment and follow-up.
(Handouts)

Resistance Testing
Todd S. Wills, MD

This will be an interactive session evaluating resistance tests of patients with complex resistance patterns. Considerations for when to use genotypes, virtual phenotypes and phenotypes and use of replication capacity will be reviewed. New CCR5 tests, integrated resistance tests and new tests of T-cell activation will be highlighted.
(Handouts)

Elite Controllers
Savita Pahwa, MD

Who are elite controllers vs. long term nonprogressors and progressors? Are there lessons to be learned from natural hosts in the non-human primate world? What are the current concepts of how HIV control is maintained? This session will introduce issues of care, monitoring and treatment.
(Handouts)